MoonLake Immunotherapeutics (MLTX)
14.07
-0.54
(-3.70%)
USD |
NASDAQ |
Dec 11, 16:00
14.10
+0.03
(+0.21%)
After-Hours: 07:21
MoonLake Immunotherapeutics Total Liabilities (Quarterly): 123.14M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Baxter International, Inc. | 13.85B |
| aTyr Pharma, Inc. | 26.61M |
| BeOne Medicines Ltd. | 3.474B |
| Merus NV | 129.26M |
| AC Immune SA | 137.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 414.34M |
| Shareholders Equity (Quarterly) | 288.91M |
| Debt to Equity Ratio | 0.2621 |
| Current Ratio | 8.502 |
| Net Debt Paydown Yield | -3.17% |